Global Archaeosomes Market, By Application (Research Application, Commercial Application), Route of Administration (Oral, Subcutaneous, Intramuscular, Other Routes of Administration), Animal Type (Livestock, Companion Animal, Others)-Industry Trends and Forecast to 2029.
Market Analysis and Size
For cancer vaccines, Chagas disease, proteins and peptides, gene delivery, antigen delivery, and delivery of natural antioxidant chemicals, archaeosomes are commonly used as drug delivery systems. The main goal of this review study was to look at the uses of this unique carrier system in the pharmaceutical area.
Data Bridge Market Research analyses that the archaeosomes market is expected to grow at a CAGR of 5.00% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2019 - 2014)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Application (Research Application, Commercial Application), Route of Administration (Oral, Subcutaneous, Intramuscular, Other Routes of Administration), Animal Type (Livestock, Companion Animal, Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
DIGIRAD CORPORATION (US), Neusoft Corporation (China), CANON MEDICAL SYSTEMS CORPORATION (Japan), SurgicEye GmbH (Germany), Mediso Ltd. (Hungary), CMR Naviscan. (US), DDD-Diagnostic A/S (Denmark), Absolute Imaging Inc. (Canada), Bartec Technologies Ltd. (UK), BCL X-Ray Canada Inc. (Canada), TTG Imaging Solutions, LLC (US), Mirion Technologies (Capintec), Inc. (US), LANDAUER (US), Ashby Gorman Baker Ltd. (Belgium), Lucerno Dynamics, LLC. (US), Berthold Technologies GmbH & Co.KG (Germany), Incom, Inc. (US), Siemens (US), Koninklijke Philips N.V. (Netherlands), and Spectrum Dynamics Medical (Switzerland).
|
|
Market Opportunities
|
|
Market Definition
Archaeosomes are a form of liposome that is made up of total polar lipids that are taken from specific genera. The main characteristics of archaeosomes are that they are more resistant to oxidative stress, high temperatures, alkaline pH, phospholipase, bile salt, and serum protein activity.
Archaeosomes Market Dynamics
Drivers
- Rise in the demand of drug delivery system for cancer vaccines
Breast cancer affects 2.1 million women per year, according to the WHO, and was the most common cancer among women in 2018. The rising incidence of cancer is likely to boost market demand.
- Research and development
Research and development in liposome design is a present opportunity for biotechnology products, and it has the potential to boost market growth.
- Rise in the demand for liposome usage
Liposomes are chosen in clinics because of their low toxicity and excellent efficacy, which is propelling the industry forward.
Opportunities
In addition, the development in the drug bio distribution is further estimated to provide potential opportunities for the growth of the archaeosomes market in the coming years.
Restraints/Challenges
On the other hand, the variability regarding the drug carrier is further projected to impede the growth of the archaeosomes market in the targeted period. However, the restricting of the liposome's success by covering it with polyethylene glycol which might further challenge the growth of the archaeosomes market in the near future.
This archaeosomes market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the archaeosomes market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Covid-19 Impact on Archaeosomes Market
The pandemic of COVID-19 has had a huge impact on the archaeosomes market. Many pharmaceutical and biotechnology companies are working to create COVID-19 vaccines that are both effective and safe. To develop a COVID-19 vaccine, new technical platforms and advanced genetic engineering processes are necessary. Manufacturers are concentrating on extending clinical trials to address the epidemiological issue and establishing large-scale vaccine production. Manufacturers are moving away from traditional production platforms and toward innovative platforms. However, in the post-COVID scenario, the archaeosomes market is projected to be significantly impacted.
Global Archaeosomes Market Scope and Market Size
The archaeosomes market is segmented on the basis of application, route of administration and animal type. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Application
- Research Application
- Commercial Application
On the basis of application, the archaeosomes market is segmented into research application and commercial application.
Route of Administration
- Oral
- Subcutaneous
- Intramuscular
- Other Routes of Administration
On the basis of route of administration, the archaeosomes market is segmented into oral, subcutaneous, intramuscular and other routes of administration.
Animal Type
- Diagnostics
- Cancer
- Monogenic Disorders
- Diabetes
- Drug Discovery and Development
- Personalized Medicine
- Agriculture and Animal Research
- Others
On the basis of animal type, the archaeosomes market is segmented into livestock, companion animal and others.
Archaeosomes Market Regional Analysis/Insights
The archaeosomes market is analysed and market size insights and trends are provided by country, application, route of administration and animal type as referenced above.
The countries covered in the archaeosomes market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the archaeosomes market due to the developed healthcare infrastructure. Furthermore, the growing adoption of companion animals will further boost the growth of the archaeosomes market in the region during the forecast period.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The archaeosomes market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for archaeosomes market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the archaeosomes market. The data is available for historic period 2010-2020.
Competitive Landscape and Archaeosomes Market Share Analysis
The archaeosomes market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to archaeosomes market.
Some of the major players operating in the archaeosomes market are:
- IntelGenx Corp (Canada)
- tesa SE (Germany)
- Biondvax (Israel)
- Reckitt Benckiser Group plc. (UK)
- APR Applied Pharma Research s.a. (Switzerland)
- FFT Medical (Sweden)
- Cynapsus (Canada)
- Bioveta, a.s. (Czechia)
- Brenntag AG (Germany)
- Novavax AB (Sweden)
- Phibro Animal Health Corporation. (US)
- SEPPIC (France)
- SPI Pharma (US)
- Zoetis (US)
SKU-